Japan's First Surgical-Specialized Generative AI 'Surgical VLM' Developed to Act as a 'Brain' in the Operating Room
NQ Score
72/100
AI Summary (NQ-processed)
Direava has developed Japan's first surgical-specialized generative AI, 'Surgical VLM', which understands and discusses surgical situations in real-time. Clinical validation at Keio University Hospital demonstrated high anatomical accuracy and clinical utility. The company aims to commercialize the technology in 2026 to enhance surgical education and patient safety.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What does this AI do?
- A: It understands surgical imagery in real-time and engages in dialogue with surgeons regarding next steps and potential risks.
- Q: When will it be commercialized?
- A: The company is preparing for commercialization within 2026.